- Filed multiple patent applications
- Designed several Smart mRNAs for targeting multiple cancer types
- Lab tests successfully validated Smart mRNAs worked in actual cancer cells (Q1 2025)
- Complete full nanoparticle for pancreatic cancer (Q3 2025)
- Complete animal studies to determine toxicity and efficacy of pancreatic cancer treatment (Q1 2026)
